Ardent Health Partners, LLC

NYSE:ARDT

Medical - Care Facilities

Healthcare
$14.40 -1.54%

-$0.14 today

Market cap
$2.03B
Beta
0.84
P/E (TTM)
9.4
EPS (TTM)
$0.95
52W Low $7.71High $15.48

Volume 7.27M

Average 0.45M

ARDT Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Ardent Health Partners, LLCNYSE: ARDT

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin remains negative

Q1 FY2026 selling, general & admin was $0, compared with $1B a year earlier. Trailing-twelve-month selling, general & admin was $2.06B. Over 3 fiscal years it compounded at -29.3% a year.

Context

  • Selling, general & admin amounted to 18.9% of revenue in FY2025, down 46.3 pp from a year earlier.
  • Selling, general & admin increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 9 analysts of $3.65B (+205.9%) for the fiscal year ending Dec 2026, a step up from the -69.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$1.19B-69.3% YoY
LTMMar 2026
$2.06B-42.1% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%-13.6%+86.4 pp
1 year-69.3%+205.9%+275.2 pp
3-year CAGR-29.3%+48.5%+77.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
1.19B USD
Year-over-year change
-69.3%
4-year CAGR
-21.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How ARDT compares with its peers on the latest reported figures

  • ARDT's LTM Mar 2026 selling, general & admin of $2.06B is the highest of the 11 companies compared; the peer median is $201.59M.
  • Its year-over-year change of -42.1% is the 8th highest of 11, against a peer median of -22.1%.
  • Selling, general & admin amounts to 32.0% of revenue for ARDT, versus a peer median of 8.1%.
ARDT Competitors Peer median
Selling, General & Admin for ARDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARDTArdent Health Partners, LLCLTM Mar 2026$2.06B -42.1%-29.3%32.0%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$398.86M +7.6%+0.4%25.2%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$397.99M -22.6%+2.9%14.9%
ADUSAddus HomeCare CorporationLTM Jun 2026$312.81M +10.0%+12.3%21.2%
ASTHAstrana Health, Inc.LTM Mar 2026$235.1M +47.6%+40.9%6.7%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$215.95M -86.3%-50.3%6.3%
MDPediatrix Medical Group, Inc.LTM Sep 2026$187.24M -21.5%+1.3%9.6%
IBRXImmunityBio, Inc.LTM Sep 2026$185.41M +24.0%+12.7%101.6%
SEMSelect Medical Holdings CorporationLTM Mar 2026$160.79M -23.6%+0.3%2.9%
BKDBrookdale Senior Living Inc.LTM Sep 2026$130.43M -67.2%+1.6%4.4%
NHCNational HealthCare CorporationLTM Sep 2026$35.37M -46.3%+4.1%2.2%
Peer median (excluding ARDT) $201.59M-22.1%+2.2%8.1%

Competitors are the stored peer set for ARDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.87B5.13B5.41B5.97B6.32B
Cost of Revenue927.33M955.17M140.84M1.03B155.7M
Gross Profit3.94B4.17B5.27B4.93B6.17B
Gross Margin81.0%81.4%97.4%82.7%97.5%
Research & Development00000
Selling, General & Admin3.13B3.37B3.62B3.88B1.19B
Operating Expenses3.51B3.96B5.04B4.53B5.84B
Depreciation & Amortization137.2M138.17M140.84M146.29M155.7M
EBITDA526.93M531.7M350M574.93M497.26M
EBITDA Margin10.8%10.4%6.5%9.6%7.9%
Operating Income436.56M217.03M229.5M405.76M325.58M
Operating Margin9.0%4.2%4.2%6.8%5.1%
Interest Income00000
Interest Expense93.83M82.05M65.43M65.58M55.2M
Other Income / Expenses(140.68M)94.45M(77.89M)(42.7M)(39.23M)
Income Before Tax295.89M311.48M151.61M363.06M286.36M
Pre-Tax Margin6.1%6.1%2.8%6.1%4.5%
Income Tax Expense51.31M46.11M22.64M63.35M56.22M
Net Income154.26M188.91M50.29M210.34M135.81M
Net Margin3.2%3.7%0.9%3.5%2.1%
EPS (Basic)1.081.320.351.590.96
EPS (Diluted)1.081.320.351.580.96
Weighted Avg Shares143.26M143.26M143.26M132.44M140.76M
Weighted Avg Shares (Diluted)143.26M143.26M143.26M132.75M141.45M

Ardent Health Partners, LLC

NYSE:ARDT

Intrinsic Alpha fair value

Locked

Current Price

$14.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.